EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study

Jun Hwa Hong

Cardiovascular Prevention and Pharmacotherapy · 31.07.2026 · 8 (3) · 58-66

DOI: 10.36011/cpp.2026.8.e9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Prevention and Pharmacotherapy, erschienen am 31.07.2026. Verfasst von Jun Hwa Hong. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Diabetes Association.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To compare changes in serum leptin and ghrelin according to weight response in patients with type 2 diabetes treated with dapagliflozin, a sodium-glucose cotransporter 2 inhibitor (SGLT2i).

Methods

In this prospective single-arm interventional study, 97 patients received dapagliflozin 10 mg daily. Serum leptin and ghrelin were measured before treatment and after 3 months of dapagliflozin treatment. Participants were divided into two groups according to their 3-month glycated hemoglobin (HbA1c) level: the target group, with HbA1c ≤7.0% (n=45), and the above-target group, with HbA1c >7.0% (n=52). Additional analyses were performed according to body weight change: the weight-loss group (n=60) and the weight-gain group (n=37). Changes in serum leptin and ghrelin were compared between groups.

Results

After 3 months of treatment, the mean HbA1c level was 6.7%±0.1% in the target group and 7.3%±0.2% in the above-target group. Serum leptin and ghrelin did not differ significantly between these groups. In the weight-loss group, serum leptin decreased significantly from 7.54±3.51 to 6.60±2.40 ng/mL (P

Förderung

  • Korean Diabetes Association

Zitieren

APA

Hong, J. H. (2026). Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study. Cardiovascular Prevention and Pharmacotherapy, 8(3), 58-66. https://doi.org/10.36011/cpp.2026.8.e9

Vancouver

Hong JH. Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study. Cardiovascular Prevention and Pharmacotherapy. 2026;8(3):58-66. doi:10.36011/cpp.2026.8.e9

BibTeX
@article{Hong2026,
  author = {Hong, Jun Hwa},
  title = {Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study},
  journal = {Cardiovascular Prevention and Pharmacotherapy},
  year = {2026},
  volume = {8},
  number = {3},
  pages = {58--66},
  doi = {10.36011/cpp.2026.8.e9}
}
Kostenlos starten →